Evidence map›Paper›PMID 37284448›Full record

ArticleTheranostics2023

NOX4 is a potential therapeutic target in septic acute kidney injury by inhibiting mitochondrial dysfunction and inflammation.

Jiameng Li, Liya Wang, Bo Wang, Zhuyun Zhang, Luojia Jiang, Zheng Qin, Yuliang Zhao, Baihai Su

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Augmenting the Endogenous RBM3 Response Protects Against Burn-Induced Acute Kidney Injury by Enhancing Macrophage-Mediated Resolution of Inflammation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Pharmaceutics · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jiameng LiCenter of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.
Liya WangDepartment of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu 610041, China.
Bo WangDepartment of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu 610041, China.
Zhuyun ZhangDepartment of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu 610041, China.
Luojia JiangDepartment of Nephrology, Jiujiang No. 1 People's Hospital, Jiujiang 332000, China.
Zheng QinDepartment of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu 610041, China.
Yuliang ZhaoDepartment of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu 610041, China.
Baihai SuDepartment of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu 610041, China.
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Kidney InjurySepsisAnimalsApoptosisInflammationLipopolysaccharidesMiceMice, Inbred C57BLMitochondriaNF-kappa BReactive Oxygen SpeciesLipopolysaccharidesNF-kappa BReactive Oxygen Speciesapoptosisinflammationmitochondrial dysfunctionNOX4Septic AKI

Identifiers

PMID37284448
PMCPMC10240817
OpenAlexW4379598398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.